Skip to Content

Therapies for atopic dermatitis for special populations of patients

In this MEDtalk, April Armstrong, Professor, Associate Dean for Clinical Research at the University of Southern California, gives her perspective on four different groups of patients and how the therapies for atopic dermatitis, biologics, and JAK-inhibitors, may affect patients.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top